Certain patient characteristics increase the likelihood of developing gallstones while taking semaglutide
The synergistic effect of combining a GHRH analog with a growth hormone secretagogue creates stronger GH pulses than either peptide achieves independently
Smiddy M et al
Investigational Compound Retatrutide (also called GLP-3 or "reta") is in Phase 3 clinical trials
Semaglutide belongs to the class of GLP-1 receptor agonists and influences, among other things, appetite, satiety, and glucose metabolism
2023, Dec, 22;14 Szgi T, Borsos BN, Masic D, Radics B, Bella Z, Bnfi A, et al